发明名称 |
OLIGONUCLEOTIDE-CONTAINING PHARMACOLOGICAL COMPOSITIONS AND THEIR USE |
摘要 |
PROBLEM TO BE SOLVED: To provide therapeutic methods and compositions containing oligonucleotides suitable for administration to humans and other mammals.SOLUTION: Provided is a modified oligonucleotide of about 7 to 75 nucleotides including seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages, where the modified oligonucleotide complementary to a region of a gene associated with a pathological disorder is selected from the group consisting of the 5' UTR region, the translational start site, the 3' UTR, and the translational termination site. Also provided is a therapeutic method including oral administration of the oligonucleotide. |
申请公布号 |
JP2014088412(A) |
申请公布日期 |
2014.05.15 |
申请号 |
JP20130268225 |
申请日期 |
2013.12.26 |
申请人 |
LAKEWOOD-AMEDEX INC |
发明人 |
DALE RODERIC M K;ARROW AMY;THOMPSON TERRY |
分类号 |
A23L1/30;A61K31/7088;A61K8/60;A61K31/7125;A61K38/00;A61K48/00;A61P1/04;A61P1/10;A61P1/16;A61P3/04;A61P3/06;A61P9/12;A61P11/02;A61P13/08;A61P13/12;A61P15/00;A61P15/08;A61P15/10;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/04;A61P25/06;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/32;A61P29/00;A61P31/00;A61P31/04;A61P31/12;A61P35/00;A61P37/08;C12N15/09;C12N15/113 |
主分类号 |
A23L1/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|